Back to catalogue
№ 063 17 filings · 2021-09-02 → 2026-04-15

CENTRAL ASIA METALS PLC

CAML
Basic Resources Market cap £262m Overall fit 410 /1000

Partial fit: real copper-driven AI demand exposure and price-side operating leverage at a fair price with strong downside protection, but indirect AI exposure (price-taker commodity producer), no volume leverage (capacity constrained), and a wasting-asset profile with only ~9 years of mine life left.

Fair value range 170p–230p Mid case · £355m
Absolute upside +35.3% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Simple, transparent two-asset cash flow business with high-quality disclosure
  • Net cash balance sheet and disciplined capital allocation
  • Kounrad's bottom-quartile cost position and 2026 Kazakh MET cut are mechanical tailwinds
Limits the call
  • Sasa reserves/LoM revised down twice in three years, raising risk of further impairment
  • Valuation is highly sensitive to long-term Cu/Zn/Pb assumptions over a 9-year LoM
Methodology

Sum-of-parts DCF to 2034 plus net cash, cross-checked with EV/EBITDA and FCF multiples

In one line · bull case

Bottom-quartile copper producer with net cash and an 8% dividend yield, trading below the discounted value of its remaining 9-year mine plan, with optional upside from a long-pursued acquisition.

In one line · biggest risk

Sasa reserves and Life-of-Mine have already been revised down once and could be revised down again, eroding the largest piece of group NAV before the Board secures a replacement asset.

Drivers
AI beneficiary 35 /100
Copper-linked to electrification and data-centre buildout but as a commodity price-taker, not a differentiated AI supplier with capture-able value.
Operating leverage 60 /100
High fixed-cost mines yield ~85% incremental EBITDA margin on Cu price moves, but capacity is constrained so no volume-side upside surprise possible.
Earnings vs expectations 45 /100
Kounrad reliable, Sasa cut 2025 mid-year guidance and triggered a $117m impairment; more misses than beats overall.
Growth momentum 35 /100
Group revenue range-bound, Kounrad guidance declining in 2026, Sasa LoM truncated to 2034.
Moat 35 /100
Kounrad's bottom-quartile cost position is real but depleting; Sasa has no durable advantage and is becoming higher cost.
Earnings quality 65 /100
Cash conversion historically ~55-60% of EBITDA; 2025 had restatement and large non-cash impairment but underlying earnings clean.
Management quality 65 /100
13-year consistent capital return track record (~$420m), disciplined withdrawal from NWR auction, but no transformational M&A executed.
Cyclicality 80 /100
Direct exposure to copper, zinc and lead prices with no contract pricing; deeply cyclical.
Leverage 8 /100
Fortress balance sheet: $80m cash, debt-free, plus credit-approved $120m facility headroom.
Value-trap signals · 4
  • Declining mine lives at both assets with no near-term replacement project
  • Dividend cut from 18p to 12p in 2025 — first reduction in many years
  • Repeated reserve/resource revisions at Sasa culminating in $117m impairment
  • Sasa 2025 mid-year guidance cut on zinc and lead production

Central Asia Metals PLC (CAML) — Investment Research Note

Executive summary

CAML is an AIM-listed base-metals producer running two assets: 100% of the Kounrad SX-EW copper dump-leach operation in Kazakhstan (~13kt Cu/yr at a bottom-quartile C1 of $0.82/lb) and 100% of the Sasa zinc-lead underground mine in North Macedonia (~18kt Zn, ~25kt Pb in concentrate). EBITDA has compressed materially from $141.5m in 2021 to $101.8m in 2025 as zinc/lead prices fell from cycle highs, in-country inflation pressured costs (Sasa cost of sales rose 22% in 2025), and Sasa took a $117.5m non-cash impairment after a Life-of-Mine cut from 2039 to 2034. The most important point for valuation today is that with the dividend now reset to policy (12p, 50% of FCF), Sasa's LoM truncated to nine years, and corporate debt fully repaid, the share is effectively priced as a wasting copper/Zn-Pb cash flow until 2034 with optionality on M&A/exploration — and at ~£261m market cap it is at or modestly below the discounted value of the remaining mine plan plus net cash. 2026-03 FY 2025; 2025-03 FY 2024

Fair value estimate

  • Methodology: Sum-of-parts DCF over remaining LoM (both assets to 2034) plus net cash, cross-checked against 5–6× FCF and EV/EBITDA of 3.5–4.5×.
  • Key assumptions: 2026 base-case EBITDA ~$110–120m (Kounrad ~$95–100m at $10k/t Cu, Sasa ~$30–35m at $3.0k/t Zn, $2.0k/t Pb with 50% zinc hedge at $3,011/t); annual sustaining capex $14–17m; corporate cost ~$15m; 9–10% nominal discount rate; ARO of $37m and modest closure costs deducted at end of life; ~£0.79/$ FX.
  • Fair value range: 170–230 pence per share, implying market cap of £305m–£410m. Mid-point ~200p / £355m.
  • vs. current £261.2m market cap (~147p): approximately +36% upside to mid, +18% to +57% across the range.
  • The case for being closer to the low end: Sasa's LoM truncation may not be the last revision; head grades have declined ~10% YoY; lead TCs turning negative post-period-end pressures Sasa margin further. The case for the high end: copper at record highs in early 2026, Kazakh MET on man-made formations dropping from 8.55% to 0.855% from 1 Jan 2026 (material to Kounrad), and ~$80m of net cash carrying optionality.

Sector context

  • Sector: Basic Resources / Diversified Mining (ICB Super-Sector confirmed). Predominantly copper revenue (Kounrad ~56% of group) with secondary zinc-lead-silver from Sasa.
  • Quality vs. peers: Above-average margin profile (Kounrad EBITDA margin 75%); fortress balance sheet (net cash); but below average on mine life (only ~9 years remaining at Sasa, ~10 at Kounrad), exploration optionality, and scale.
  • Listed peers: Atalaya Mining (AIM, Spanish copper), Capstone Copper (mid-cap copper), Boliden (Sasa peer on Zn-Pb). At ~3.5–4× EBITDA, CAML trades at a discount to peers reflecting AIM listing, short mine life and Macedonian/Kazakh geographic risk.

Investment thesis

  • Bottom-quartile copper producer with a sweetened tax environment from 2026 — Kounrad's 2025 C1 of $0.82/lb is in the global lowest quartile; Kazakh MET legislation drops the applicable rate on man-made formations like Kounrad from 8.55% to 0.855% effective 1 January 2026, which on 2025 MET of $11.4m is a ~$10m annual cash benefit to Kounrad (worth ~5% of group EBITDA before tax). 2026-03 FY 2025
  • Net-cash balance sheet creates real optionality — $80m cash, debt-free; the Board showed capital discipline by withdrawing from the New World Resources bidding war in mid-2025, receiving a $1.6m break fee and a $2.5m profit on its 12.1% stake. With $120m of credit-approved facilities from BMO/ING/SocGen still on the table from the NWR deal, CAML has $200m+ of acquisition firepower at a moment when copper M&A premia for tier-one assets are high but for mid-tier producers may be more reasonable. 2025-05 NWR proposal; 2026-03 FY 2025
  • Above-policy dividend yield with restored discipline — Reset 2025 dividend of 12p is at the top of the 30–50% FCF policy range, implying a ~8% yield at the current price plus a completed $10m buyback. Combined with ~$78m net cash, the cash return profile is supportive while management pursues a "material transaction". 2026-03 FY 2025

Key risks

  • Sasa mine plan may not have bottomed — Ore Reserve cut 25% (from 9.2Mt to 6.9Mt) in 2025; head grades have declined ~10% YoY and orebody variability is increasing with depth; the LoM was already cut from 2039 to 2034 and Golema Reka was excluded from the plan. Further reserve/cost revisions could trigger additional impairments. 2026-03 FY 2025
  • Limited remaining life and no near-term replacement — Both assets end ~2034; Aberdeen Minerals stake (32.6%) and CAML X exploration are early-stage with no resource yet defined. If the "material transaction" the Board has been pursuing for 4+ years does not materialise, equity holders face a wasting-asset path. 2026-03 FY 2025; 2025-09 H1 2025
  • Commodity price and geographic concentration — Revenue is 56% Cu, with the remainder Zn/Pb/Ag; both assets are in jurisdictions (Kazakhstan, North Macedonia) with elevated political and currency risk. Zinc TCs are forecast to rise from 2025 historic lows, and the Macedonian Denar has strengthened against USD, both pressuring Sasa. 2026-03 FY 2025

Operating leverage

CAML has strong price-side operating leverage but limited volume leverage. Cost base is largely fixed: Kounrad's 75% EBITDA margin and bottom-quartile C1 of $0.82/lb mean ~85% of incremental copper revenue at current prices drops to EBITDA. Group EBITDA fell from $141.5m (2021) to $101.8m (2025) on roughly flat production but lower zinc prices — illustrating high price sensitivity. Conversely, capacity is constrained: Kounrad is limited by remaining leachable copper in the dumps (guidance declining 12–13kt in 2026 vs. 13.3kt in 2025) and Sasa is capped at ~830kt of ore p.a. A 10% increase in Cu/Zn/Pb prices is disclosed to flow ~$22m to earnings/equity, roughly 7% of market cap. Where this matters less for the AI thesis: there is no operational lever to expand output if copper rallies further — CAML cannot benefit from a volume surprise the way a software business with spare capacity could. 2026-03 FY 2025 Note 4

Value-trap signals

  • Declining mine lives at both assets with no replacement projects yet de-risked
  • Dividend cut from 18p (2024) to 12p (2025) — first reduction in many years, signalling management's view that prior payouts were above sustainable run-rate
  • Repeated reserve/resource revisions at Sasa culminating in a $117m impairment
  • Mid-year 2025 production guidance cut at Sasa (zinc/lead in concentrate) due to orebody variability — geology is becoming more challenging with depth
  • Net loss of $75m in 2025 even with the impairment stripped out leaves only $32.6m adjusted profit on a £261m market cap (~12.5× adjusted PE) — reasonable but not cheap given the wasting profile

Earnings vs. expectations

Across the period, CAML has been a beat-or-meet operator at Kounrad and a guidance-cutter at Sasa. Kounrad delivered "well within guidance" in 2025 (13,311t Cu vs. 13,000–14,000t target) and similarly in 2023 and 2024. Sasa met original 2022 and 2024 guidance but missed initial 2021 guidance, cut mid-year 2025 guidance on zinc and lead, and met the revised 2025 numbers only in Q4. Analyst consensus is not reproduced in the filings. Pattern: when surprises happen, they tend to be negative and concentrated at Sasa. 2026-03 FY 2025; 2025-09 H1 2025; 2025-03 FY 2024; 2024-03 FY 2023

Conviction

3 (moderate). Anchored by: (i) the business model is genuinely simple — two operating assets, both cash-generative, debt-free balance sheet, clear policy on capital returns; (ii) disclosure is high quality with auditable cost detail; (iii) Kounrad's cost position is durable and the 2026 MET cut is mechanical upside. Limited by: (i) Sasa LoM and reserves estimates have moved adversely twice in three years, undermining confidence in the long-term cash flow base; (ii) M&A is the key longer-term value driver and is binary and hard to forecast; (iii) any DCF is highly sensitive to copper/zinc price assumptions, where a 5% reduction in zinc price or 6% in lead would close the headroom Sasa shows in its impairment sensitivities.

Driver scoring rationale

  • AI beneficiary (35): Copper is structurally exposed to electrification and data-centre buildout, and management explicitly cites "infrastructure for artificial intelligence" supporting prices. But CAML is a price-taking commodity producer — value flows to whichever miner has the marginal tonne, not specifically to CAML. No demonstrable AI-driven revenue line, productivity moat, or addressable-market expansion CAML can uniquely capture.
  • Operating leverage (60): High fixed-cost base at Kounrad gives 75% EBITDA margins; ~85% incremental margin on Cu price moves; but capacity is constrained on the volume side. Sensitivity table shows $22m EBITDA on 10% commodity move.
  • Earnings surprise trend (45): Kounrad consistently meets; Sasa has cut guidance more than once and triggered a major impairment. Net: more misses than beats over the three-year window.
  • Cyclicality (80): Direct commodity price taker on Cu/Zn/Pb.
  • Moat (35): Kounrad has a real bottom-quartile cost moat but it is asset-specific and depleting; Sasa has no meaningful moat and is becoming higher-cost.
  • Leverage (8): Net cash, no debt, $200m+ of facility + cash for M&A.
  • Earnings quality (65): Cash conversion historically strong (FCF/EBITDA ~55–60%); 2025 had a prior-year restatement on inventory unrealised profit and a large non-cash impairment; otherwise clean.
  • Management quality (65): 13 years of consistent capital returns (~$420m), disciplined withdrawal from NWR auction, but limited M&A execution to date.
  • Growth momentum (35): Production declining at Kounrad in 2026, Sasa guidance up but off a low 2025 base, group revenue range-bound.

Overall fit assessment

The investor wants AI receivers with operating leverage at a fair price. CAML is partially aligned: copper exposure (genuinely AI-related demand) + good price-side operating leverage + a sensible valuation + fortress balance sheet downside protection. It is not aligned on: indirect AI exposure (commodity price taker, not differentiated), no volume-side operating leverage (capacity constrained, depleting), and the wasting-asset profile. Score: low end of the "partial fit" band.

Filings consulted · 23

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-04-15Annual Report And Accounts 2025 And Notice OF Agm2026-04-15_9521385_annual-report-and-accounts-2025-and-notice-of-agm.md0.95
  2. 2026-03-192025 Full Year Results2026-03-19_9481418_2025-full-year-results.md1.00
  3. 2025-09-10Interim Results For Six Months Ended 30 June 20252025-09-10_9097744_interim-results-for-six-months-ended-30-june-2025.md0.77
  4. 2025-08-21Notice OF Interim Results2025-08-21_9066847_notice-of-interim-results.md0.77
  5. 2025-07-21Update ON New World Resources Acquisition2025-07-21_8987959_update-on-new-world-resources-acquisition.md0.64
  6. 2025-05-21Proposed Acquisition OF New World Resources2025-05-21_8888759_proposed-acquisition-of-new-world-resources.md0.49
  7. 2025-04-15Annual Report And Accounts 2024 And Notice OF Agm2025-04-15_8831952_annual-report-and-accounts-2024-and-notice-of-agm.md0.62
  8. 2025-04-09Disposal OF Copper Bay2025-04-09_8820813_disposal-of-copper-bay.md0.49
  9. 2025-03-202024 Full Year Results2025-03-20_8788026_2024-full-year-results.md0.65
  10. 2024-09-10Interim Results For Six Months Ended 30 June 20242024-09-10_8407830_interim-results-for-six-months-ended-30-june-2024.md0.58
  11. 2024-08-20Notice OF Interim Results2024-08-20_8374471_notice-of-interim-results.md0.58
  12. 2024-04-18Annual Report And Accounts 2023 And Notice OF Agm2024-04-18_8145598_annual-report-and-accounts-2023-and-notice-of-agm.md0.43
  13. 2024-03-252023 Full Year Results2024-03-25_8103679_2023-full-year-results.md0.45
  14. 2023-09-13Interim Results For Six Months Ended 30 June 20232023-09-13_7751780_interim-results-for-six-months-ended-30-june-2023.md0.41
  15. 2023-08-23Notice OF Interim Results2023-08-23_7711869_notice-of-interim-results.md0.41
  16. 2023-04-20Annual Report And Accounts 2022 And Agm Notice2023-04-20_7492544_annual-report-and-accounts-2022-and-agm-notice.md0.24
  17. 2023-03-292022 Full Year Results2023-03-29_7339790_2022-full-year-results.md0.25
  18. 2022-09-14Interim Results For Six Months Ended 30 June 20222022-09-14_7314081_interim-results-for-six-months-ended-30-june-2022.md0.23
  19. 2022-08-23Notice OF Interim Results2022-08-23_7189227_notice-of-interim-results.md0.23
  20. 2022-04-21Annual Report Amp Accounts 2021 Amp Notice OF 2022 Agm2022-04-21_7037427_annual-report-amp-accounts-2021-amp-notice-of-2022-agm.md0.24
  21. 2022-03-292021 Full Year Results2022-03-29_7091820_2021-full-year-results.md0.25
  22. 2021-09-15Interim Results2021-09-15_6827272_interim-results.md0.23
  23. 2021-09-02Notice OF 2021 Interim Results2021-09-02_6716398_notice-of-2021-interim-results.md0.23

This research note was authored by a large language model after reading 17 regulatory filings published between 2021-09-02 and 2026-04-15. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.